Header Logo

Connection

Bethany Hannafon to Antineoplastic Agents

This is a "connection" page, showing publications Bethany Hannafon has written about Antineoplastic Agents.
Connection Strength

0.964
  1. Oklahoma nitrone-007 is an effective anticancer therapeutic agent targeting inflammatory and immune metabolism pathways in endometrial cancer. J Pharmacol Exp Ther. 2025 Jan; 392(1):100004.
    View in: PubMed
    Score: 0.638
  2. Sorafenib and docosahexaenoic acid act in synergy to suppress cancer cell viability: a role of heme oxygenase 1. BMC Cancer. 2018 Oct 26; 18(1):1042.
    View in: PubMed
    Score: 0.105
  3. Docosahexaenoic acid and disulfiram act in concert to kill cancer cells: a mutual enhancement of their anticancer actions. Oncotarget. 2017 Mar 14; 8(11):17908-17920.
    View in: PubMed
    Score: 0.094
  4. Disulfiram's Anticancer Activity: Evidence and Mechanisms. Anticancer Agents Med Chem. 2016; 16(11):1378-1384.
    View in: PubMed
    Score: 0.086
  5. Flexible heteroarotinoids (Flex-Hets) exhibit improved therapeutic ratios as anti-cancer agents over retinoic acid receptor agonists. Invest New Drugs. 2005 Oct; 23(5):417-28.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.